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Abstract 
What is the risk that use of antibiotics in farm animals will result in treatment failure in humans? 
Different approaches can address this. One approach is to make a risk profile and another to 
conduct a risk assessment. Use of macrolides in Danish pigs will be used as an example that 
demonstrates how the conclusion depends on the approach. A risk profile mcludes a description of 
the hazard and a qualitative assessment of the risk, simi lar to hazard identification. Accordingly, 
macrolide-resistant Campylobacter might develop as a result of usage of macrolides in p1g 
production. This is of concern for human health. because it might reduce the effect of erythromycin , 
a macrolide used in chi ldren for treatment of Campylobacter infections. A full risk assessment 
contains an assessment of release, exposure, and consequences related to the unwanted 
outcome. Release deals with the probability that Campylobacterwill be present m the gut, and how 
often the isolates found are resistant to macrolides. Exposure relates to the probability of a person 
being exposed to macrolide-resistant Campylobacter, and here the prevalence in pork - and not 
live pigs - is of interest. The consequences deal with the outcome of exposure· likelihood of 
disease/adverse effects. Campylobacter is commonly occurring in the pig gut, and so is macrolide-
resistance in Campylobacter in pigs. However, the prevalence of Campy/obacter in Dan1sh pork at 
retai l is negligible because of use of blast-chilling after slaughter. Human campylobactenos1s IS 
usually self-limiting. One study describes adverse effects related to infection with macrolide-
resistant Campylobacter- but the effect was severely confounded with age and co-morbidity, and 
no children got adversely affected. So according to the risk assessment, the risk associated with 
veterinary use of macrolldes in Danish pigs for the health of humans seemed low. Th1s IS contrary 
to the resu lt obtained by the risk profile. 
Introduction 
Veterinary usage of antibiotics might resu lt in development of resistance among zoonot1c bacteria 
or non-pathogenic microorgamsms. The fear is that treatment failure of humans will occur as a 
result of infection with zoonotic bacteria originating from e.g. pigs or poultry treated w1th antibiotics. 
Moreover, transfer of resistance from non-pathogenic microorganisms to human pathogens might 
occur, and examples of this have been observed. The World Health Organization (WHO) has re-
servations about veterinary use of macrolides, because of the risk of development of macrolide-
resistant Campylobacter. In particular, chi ldren are of concern, because macrolides are the drug of 
choice for treatment of intestinal disorders in children (WHO, 2005). In line, The US Federal Drug 
Agency (FDA) considers vetennary usage of macrolides as a nsk for human health (FDA, 2003). 
To mitigate th1s risk, usage of antibiotics as growth promoters has gradually been banned w1thin 
the European Un1on (EU) (Anon., 1998; Anon ., 2003). In July 1999, the EU suspended four 
antimicrobial growth promoters; bacitracin , wgin1amycm, sp1ramycin and tylosin (Anon., 1998) 
In 2006, the Damsh Vetennary & Food Administration decided to redraw macrolldes from the list of 
drugs recommended for treatment of diarrhea 1n p1gs. The dec1s1on was dnven by a political 
interest in reducing the antib1ollc consumption per se as well as evidence pointing at a specific risk 
related to macrolides. The decis1on to leave out macrolides was taken based on a nsk profile, in 
line with the precautionary principle, which can be used to take preliminary dec1s1ons. 
A full nsk assessment is then a natural step - to study whether in fact the decision taken IS JUStified 
or not. Therefore, a risk assessment following mternat1onal guidelines was conducted by the 
Damsh Meat Association aiming at assessing the risk for human health assoc1ated with usage of 
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macrolides tn Dantsh ptgs In the followtng it will be demonstrated how the esttmated risk depends 
on the approach taken: risk profile or quantttattve nsk assessment. 
Materials and Methods 
lnttlally we tdenttfied macrolide-reststant Campylobacter as the agent of interest based on two 
cnteria 1) it should be a zoonotic bactenum that causes disease in humans and 2) macrolides 
should be the drug of chotce for treatment of disease. Data on prevalence of Campylobacter tn beef, 
pork, poultry meat and humans as well as on macrolide-resistant Campylobacter were obtamed from 
national and international surveys primarily from 2004 In particular, data from EU surveillance were 
obtained from the EFSA report (EFSA, 2005). Moreover, tnformation on antibto!tc consumptton. meat 
import statistics and consumpttons patterns were obtatned. Information from published papers on the 
consequences related to human infection with Campylobacterwas also incorporated. 
We decided to tnclude pork and poultry m the analysis, whereas we Interpreted pets as carriers of 
Campylobacter from pork and poultry, because pets often share food with their owners. Beef was 
ruled out because 11 was an tnstgntficant source of macrolide-resistant Campylobacter. 
A nsk profile mcludes a description of the hazard and a qualitative assessment of the risk, similar 
to hazard tdentificatton A nsk assessment ts an extenston because ts tmplies an evaluation of 
each of the following steps 
1 Hazard identification 
2 Release assessment 
3 Exposure assessment 
4 Consequence assessment 
5. Risk esttmatton 
A quantitattve model was constructed tn the software programme @Risk 
Results 
Risk proflle 
Accordtng to the nsk profile, macrolide-reststant Campylobacter might develop as a result of usage 
of macrolides tn animal production This is of concern for human health, because 1! mtght reduce 
the effect of erythromycin, a macrolide used tn children for treatment of Campylobacter mfecttons. 
In 2004, approximately 131 of macrolides were used for therapeutic treatment tn Denmark 
(DANMAP, 2004). Around 92% of thts was used for a productton of 23m fintshers as well as an 
export of 2m piglets (DANMAP, 2004, Anon . 2005b). This corresponds to around 0 .5g macrolides 
per produced ptg (131 x 0 92 /25m ptgs = 0 48g macrolides I pig). The matn part (87%) of the 
consumption tn ptgs was used for weaners and fintshers. Only around 50kg of macrolides were 
used in cattle, and here, half of tt was used tn adult cattle and half tn calves <12months of age. In 
poultry, around 15kg were used (DANMAP, 2004). This common use selects for development of 
macrolide-resistance in Campylobacter (Fnmodt-M0IIer and Hammerum, 2004). Secondly, a 
Danish study recently published, demonstrated an excess risk of invasiveness or dying among 
patients tnfected with macrolide-reststant Campylobacter (Helms et al , 2005). Based on thts 
tnformation tt was JUdged that use of macrolides for treatment of pigs might lead to development of 
macrolide-resistant Campylobacter which again constitutes an tncreased nsk for humans 
Risk assessment 
The release assessment showed that thermophtlic Campylobacter spp are widespread in nature 
and the prmciple reservoirs are the alimentary tract of wild and domestic btrds and mammals In 
poultry and cattle, C jejuni is the most commonly found spectes, whereas C colt is most common 
tn pigs (Stern & Lme 2000) There is a moderate to high prevalence of macrolide-reststant 
Campylobacter m live ptgs tncludmg Danish pigs presumably as a result of usage of macrolides in 
ptg production In poultry the macrohde-reststance m Campylobacter ts less common and probably 
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a result of the use of antimicrobial growth promoters (virginiamycin and spiramycin) in broilers in 
EU before year 2000. 
The exposure assessment showed that the prevalence of Campylobacter m pork IS low, and 
espec1ally low in Danish pork due to blast chilling. In poultry, the proportion of Campy/obacter 
isolates that are macrolide-resistant is much lower than in pork however; th1s IS counteracted by 
the h1gh prevalence of Campylobacter found in poultry in general. The exposure model for 2004 
data showed that the usage of macrolides in Danish pig production was associated with seven 
human cases only. The main part of the cases was related to imported meat; pork (83 cases) or 
poultry meat (74 cases). 
Table 1 
Description of 1nput parameters used in a model describing the source of exposure of Danes to 
macrolide-resistant Campylobacter due to consumption of pork or poultry meat, 2004 
Vanable Parameter est1mate Derived distribution Source 
Relative consumption 1 4 t1mes more pork is 8 GfK Consumer Scan , GfK 
of pork compared to consumed than poultry 1n Denmark 
poultry Denmark on average 
Distribution of orig1n Domestic: 75% 
of ork lm orted: 25% 
Distrib-ution of origin Nat1onally 65% 
of poultry Imported· 35% 
Prevalence of Domestic: 0.2% 
Campylobacter 1n Imported 1n general 5% or 
pork lower, however higher 
prevalences also observed 
Proportion that is 
macrohde-res1stant 
Domestic: 23% 
Imported· varymg greatly 
Statistics from Danish--
Meat Assoc1at1on, 2006 
Statistics from Damsh 
Meat Association, 2006 
Beta(s-5·-. -n-~2::-,4~1:-::3:-:-) -::E:;;:F-;;S-:-A-:, 2;;-;0~05 - -
Pert (0%, 5%; 20%) 
DANMAP, 2004 
Beta(s=23,n=100) EFSA, 2005 
Prevalence of 
Campy/obacter 1n 
poultry 
Pert(16%,24%,78%) Authors' best uess Domeslic-:"""2~3-5~o/c.,..o ------,s=-e"""t'""'a{7s"--='-:"13="7==-. '-n;;..:.=-=-58::-4,;,.)'----c=D:-:A-:-N':':"':MAP, 2004 
Imported varies greatly Pert(2%, 30%, 89%) EFSA, 2005 
Proport1onb that1s 
macrolide-res1stant 
Human cases due to 
macrolide-resistant 
(Mres) 
campylobactenosis 
Domest1c: C JeJun~: 0 5% 
C COli: 3% 
Imported C JeJuni· 3% 
C coli· 12% 
3,724 human 
Campylobacter cases in 
2004 
1997-2000 5.9% Mres C. 
1997-2004· 0-5% Mres C 
1 O%"b 
5% "" 186 cases• 
DANMAP, 2004 
Anon., 2005a, Helms et al , 
2005 
a No attempt was made to model the variability associated w1th these parameters 
b: The distribution between C. ;ejuni and C. coli 1n poultry meat was assumed to be 80·20 in line w1th Nielsen et al 
(2005), hence 1n domestic produced poultry the proportion or Campylobacter 1solates that is macrolide-resistant IS 0.8 x 
0.5% + 0 2 x 3.0% = 1% Sim1larly, for Imported poultry: 0.8 x 3% + 0.2 x 12% = 4 8% In pork, all Isolates were assumed 
to be C. coli 
The consequences assessment showed that in 2004 an incidence of human campylobacteriosis of 
68.8 cases per 100,000 inhabitants m Denmark corresponding to 3,724 cases (Anon , 2005a). The 
disease is usually self-limiting with symptoms lastmg less than seven days Apparently, an excess 
nsk of Invasiveness and death among patients infected with Campy/obacter has been observed by 
Helms et al. (2005). However, the effect of macrolide-resistance found in that study was 
confounded by age (only old people at risk) and co-morbidity, and non-significant when evaluated 
for 0 to 30 days of infection (Helms et al., 2005). In addition, m the study by Helms et al. (2005) no 
children infected with macrolide-res1stant Campy/obacter had mvas1ve mfect1on or d1ed, and these 
were the ones that WHO were concerned with. Overall speakmg, the consequences seemed to be 
negligible for children and adults, and low for old people The crude data showed that pat1ents 
mfected w1th macrolide-resistant Campylobacter had a probability of 3 4% of expenencmg mvas1ve 
infection or death (Helms et al. , 2005). Th1s Implies that for the year 2004, 7 cases x 0 034 = 0 2 
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human cases w1th adverse effect due to Danish pork could have been expected - when 
disregarding the confounding effect of age and co-morbidity, and the baseline risk associated with 
Campy/obacler. 
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Figure 1 
Graphical description of model used to assess the distribution of exposure of humans in Denmark 
to macrolide-resistant Campylobacter in pork or poultry meat of domestic or imported origin based 
on data from 2004 
Discussion 
The present study demonstrates that the use of the pre-cautionary principle is a preliminary activity 
that should be utilized when there 1s concern about a given activity/hazard. However, a full risk 
assessment is also required because 11 m1ght yield a different conclusion about the concerned risk 
than when only undertaking a nsk-profile. When performmg risk assessments, 1nternat1onal 
guidelines should be followed. Ideally, the assessment should be subjected to peer-review and an 
open debate should be held among stakeholders to ensure quality, validity and common 
understandmg of the nsk assessment. The results of such a nsk assessment constitute the optimal 
scientific basis of management decisions (Vose et al. , 2001 ). 
Conclus ions 
The nsk associated with veterinary use of macrolides m Danish pigs for human health because of 
macrohde-res1stant Campylobacter seems to be negligible to low. A further reduction in the usage 
of macrol ides in Danish pig production will therefore have limited effect on the number of human 
cases w1th adverse effects due to exposure of Danes to macrolide-res1stant Campylobacter 
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